FR2884419B1 - Composition de type solution filmogene comprenant de la vitamine d ou un de ses derives et un corticosteroide, et son utilisation en dermatologie - Google Patents

Composition de type solution filmogene comprenant de la vitamine d ou un de ses derives et un corticosteroide, et son utilisation en dermatologie

Info

Publication number
FR2884419B1
FR2884419B1 FR0503913A FR0503913A FR2884419B1 FR 2884419 B1 FR2884419 B1 FR 2884419B1 FR 0503913 A FR0503913 A FR 0503913A FR 0503913 A FR0503913 A FR 0503913A FR 2884419 B1 FR2884419 B1 FR 2884419B1
Authority
FR
France
Prior art keywords
filmogenous
dermatology
corticosteroid
vitamin
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0503913A
Other languages
English (en)
Other versions
FR2884419A1 (fr
Inventor
Claire Mallard
Laurent Fredon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Galderma SA
Original Assignee
Galderma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galderma SA filed Critical Galderma SA
Priority to FR0503913A priority Critical patent/FR2884419B1/fr
Priority to EP06753522A priority patent/EP1874320A1/fr
Priority to PCT/EP2006/004315 priority patent/WO2006111426A1/fr
Publication of FR2884419A1 publication Critical patent/FR2884419A1/fr
Application granted granted Critical
Publication of FR2884419B1 publication Critical patent/FR2884419B1/fr
Priority to US11/976,066 priority patent/US20080118453A1/en
Priority to US12/983,608 priority patent/US20110300086A1/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q3/00—Manicure or pedicure preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
FR0503913A 2005-04-19 2005-04-19 Composition de type solution filmogene comprenant de la vitamine d ou un de ses derives et un corticosteroide, et son utilisation en dermatologie Expired - Fee Related FR2884419B1 (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
FR0503913A FR2884419B1 (fr) 2005-04-19 2005-04-19 Composition de type solution filmogene comprenant de la vitamine d ou un de ses derives et un corticosteroide, et son utilisation en dermatologie
EP06753522A EP1874320A1 (fr) 2005-04-19 2006-04-14 Composition d'une solution de type filmogene, comprenant de la vitamine d ou un de ses derives et un corticosteroide, et son utilisation en dermatologie
PCT/EP2006/004315 WO2006111426A1 (fr) 2005-04-19 2006-04-14 Composition d'une solution de type filmogene, comprenant de la vitamine d ou un de ses derives et un corticosteroide, et son utilisation en dermatologie
US11/976,066 US20080118453A1 (en) 2005-04-19 2007-10-19 Film-forming solutions comprising vitamin D or derivative thereof and a corticosteroid and dermatological applications thereof
US12/983,608 US20110300086A1 (en) 2005-04-19 2011-01-03 Film-Forming Solutions Comprising Vitamin D or Derivative Thereof and a Corticosteroid and Dermatological Applications Thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0503913A FR2884419B1 (fr) 2005-04-19 2005-04-19 Composition de type solution filmogene comprenant de la vitamine d ou un de ses derives et un corticosteroide, et son utilisation en dermatologie

Publications (2)

Publication Number Publication Date
FR2884419A1 FR2884419A1 (fr) 2006-10-20
FR2884419B1 true FR2884419B1 (fr) 2007-06-22

Family

ID=35428017

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0503913A Expired - Fee Related FR2884419B1 (fr) 2005-04-19 2005-04-19 Composition de type solution filmogene comprenant de la vitamine d ou un de ses derives et un corticosteroide, et son utilisation en dermatologie

Country Status (2)

Country Link
US (2) US20080118453A1 (fr)
FR (1) FR2884419B1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5833007B2 (ja) 2009-08-31 2015-12-16 ドクター・レディーズ・ラボラトリーズ・リミテッド ステロイドを含む局所製剤
US20160184431A1 (en) 2014-03-11 2016-06-30 Promius Pharma Llc Topical compositions comprising a corticosteroid

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1272953A (fr) * 1984-10-08 1990-08-21 Yuji Makino Compose pharmaceutique pour usage externe contenant de la vitasmine d.sub.3 de type acitf
IL99368A (en) * 1991-09-02 1996-01-19 Teva Pharma Preparations for the treatment of psoriasis and atopic dermatitis, which contain the result of xanthine
DK128494A (da) * 1994-11-08 1996-05-09 Edel K Seidenschnur Behandling af keratinøse og psoriatiske sygdomstilstande med neglelak indeholdende vitamin D metabolit, eller derivat, og/eller vitamin A derivat
US5696164A (en) * 1994-12-22 1997-12-09 Johnson & Johnson Consumer Products, Inc. Antifungal treatment of nails
RO118174B1 (ro) * 1997-08-21 2003-03-28 Aventis Pharma Deutschland Gmbh Lac de unghii şi utilizarea acestuia
US6231875B1 (en) * 1998-03-31 2001-05-15 Johnson & Johnson Consumer Companies, Inc. Acidified composition for topical treatment of nail and skin conditions
PT1178808E (pt) * 1999-04-23 2012-08-16 Leo Pharma As Composição farmacêutica não aquosa para utilização dérmica para o tratamento da psoríase compreendendo uma vitamina d, um corticosteróide e de um componente solvente
CA2492976C (fr) * 2002-09-05 2011-11-01 Galderma Research & Development, S.N.C. Solution destinee a une application ungueale et peri-ungueale
FR2848454B1 (fr) * 2002-12-17 2007-03-30 Galderma Res & Dev Composition pharmaceutique comprenant une association de calcitriol et d'un corticosteroide
US20070280972A1 (en) * 2006-04-25 2007-12-06 Zars, Inc. Adhesive solid gel-forming formulations for dermal drug delivery

Also Published As

Publication number Publication date
US20110300086A1 (en) 2011-12-08
US20080118453A1 (en) 2008-05-22
FR2884419A1 (fr) 2006-10-20

Similar Documents

Publication Publication Date Title
NO20052496D0 (no) Selekterte CGRP antagonister, fremgangsmater for fremstilling derav og anvendelse derav som medikamenter.
CL2007002017A1 (es) Compuestos derivados de [4,5']-bipirimidinil-6,4'-diamina; composicion farmaceutica; y uso como inhibidor de la actividad de cinasa en cancer de vejiga, cancer cervical y mieloma multiple.
MA28512B1 (fr) Derive heterocyclique accole, composition medicamenteuse en contenant, et son utilisation medicamenteuse
FR2885527B1 (fr) Composition pharmaceutique comprenant un onguent oleagineux et de la vitamine d ou ses derives a l'etat solubilise
BRPI0511396A (pt) derivados de retinal e métodos para uso no tratamento de enfermidades visuais
DK1792927T3 (da) Ny blokcopolymer, micelletilberedning og anticancermiddel indeholdende samme som aktiv ingrediens
DK1615646T4 (da) Farmaceutiske formuleringer, der indeholder methylnaltrexon
DE502005002105D1 (de) 4-benzimidazol-2-yl-pyridazin-3-on-derivative, ihre herstellung und verwendung in arzneimitteln
PT1500654E (pt) Derivados de benzoxazinona, sua preparacao e utilizacao como medicamentos
TWI347844B (en) Sulfoximine-substituted pyrimidines as cdk-and/or vegf inhibitors, their production and use as pharmaceutical agents
NL1027596A1 (nl) Stationair computertomografiesysteem en werkwijze.
ATE549019T1 (de) 1-ä(3-hydroxy-adamant-1-ylamino)-acetylü- pyrrolidin-2(s)-carbonitril-formulierung mit modifizierter freisetzung
IL177533A (en) Benzimidazole derivatives, their preparation and pharmaceutical compositions comprising them
FR2840903B1 (fr) Derive de glucose et de vitamine f, compositions le comprenant et utilisations pour ameliorer l'etat des poils et des cheveux
ITMI20031570A1 (it) Composizione per uso dietetico, farmaceutico o cosmetico
ITRM20030204A0 (it) Formulazione dermatologica.
EP1951185A4 (fr) Formule à usage local contenant du latex ou une fraction de latex, et méthode de traitement cosmétique
FR2900819B1 (fr) Compose de type bis-uree, composition le comprenant, utilisation et procede de traitement cosmetique
MA28720B1 (fr) Derives de tetrahydroisoquinolilsulfonamides, leur preparation et leur utilisation en therapeutique
DK1670769T3 (da) Benzimidazol-derivater, sammensætninger indeholdende disse, fremstilling deraf og anvendelser deraf
FR2876029B1 (fr) Composition cosmetique et/ou dermatologique pour peaux sensibles.
FR2881647B1 (fr) Composition cosmetique ou dermatologique contenant un derive de glucose et de vitamine f et un tensioactif specifique
BRPI0517782A (pt) formulações de benzotiazol e uso das mesmas
ATE491710T1 (de) 2-substituierte phenyl-5,7-dialkyl-3,7- dihydropyrrolä2,3-dü pyrimidin-4-onderivate, deren herstellung und pharmazeutische verwendung
DK1464341T3 (da) Ubiquinon-holdig, vandopløselig formulering til ophthalmisk anvendelse

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20121228